CVS Health Statistics

Total Valuation

CVS Health has a market cap or net worth of CAD 141.95 billion. The enterprise value is 237.04 billion.

Market Cap	141.95B
Enterprise Value	237.04B

Important Dates

The next estimated earnings date is Wednesday, May 6, 2026.

Earnings Date	May 6, 2026
Ex-Dividend Date	Apr 23, 2026

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.71%
Shares Change (QoQ)	+0.63%
Owned by Insiders (%)	0.10%
Owned by Institutions (%)	88.95%
Float	1.28B

Valuation Ratios

The trailing PE ratio is 58.56 and the forward PE ratio is 11.29.

PE Ratio	58.56
Forward PE	11.29
PS Ratio	0.26
PB Ratio	1.37
P/TBV Ratio	n/a
P/FCF Ratio	13.26
P/OCF Ratio	9.73
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.82, with an EV/FCF ratio of 22.14.

EV / Earnings	97.78
EV / Sales	0.43
EV / EBITDA	9.82
EV / EBIT	17.30
EV / FCF	22.14

Financial Position

The company has a current ratio of 0.84, with a Debt / Equity ratio of 1.06.

Current Ratio	0.84
Quick Ratio	0.57
Debt / Equity	1.06
Debt / EBITDA	4.53
Debt / FCF	10.24
Interest Coverage	3.21

Financial Efficiency

Return on equity (ROE) is 2.29% and return on invested capital (ROIC) is 5.62%.

Return on Equity (ROE)	2.29%
Return on Assets (ROA)	2.47%
Return on Invested Capital (ROIC)	5.62%
Return on Capital Employed (ROCE)	6.08%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	2.11M
Profits Per Employee	9,342
Employee Count	259,500
Asset Turnover	1.58
Inventory Turnover	18.56

Taxes

In the past 12 months, CVS Health has paid 559.42 million in taxes.

Income Tax	559.42M
Effective Tax Rate	19.10%

Stock Price Statistics

The stock price has increased by +21.04% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+21.04%
50-Day Moving Average	18.43
200-Day Moving Average	18.20
Relative Strength Index (RSI)	63.27
Average Volume (20 Days)	2,466

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.26

Income Statement

In the last 12 months, CVS Health had revenue of CAD 548.22 billion and earned 2.42 billion in profits. Earnings per share was 1.91.

Revenue	548.22B
Gross Profit	72.85B
Operating Income	13.74B
Pretax Income	2.93B
Net Income	2.42B
EBITDA	20.05B
EBIT	13.74B
Earnings Per Share (EPS)	1.91

Balance Sheet

The company has 14.53 billion in cash and 109.62 billion in debt, giving a net cash position of -95.09 billion.

Cash & Cash Equivalents	14.53B
Total Debt	109.62B
Net Cash	-95.09B
Net Cash Per Share	n/a
Equity (Book Value)	103.36B
Book Value Per Share	81.14
Working Capital	-19.17B

Cash Flow

In the last 12 months, operating cash flow was 14.59 billion and capital expenditures -3.88 billion, giving a free cash flow of 10.70 billion.

Operating Cash Flow	14.59B
Capital Expenditures	-3.88B
Depreciation & Amortization	6.30B
Net Borrowing	-2.43B
Free Cash Flow	10.70B
FCF Per Share	n/a

Margins

Gross margin is 13.29%, with operating and profit margins of 2.51% and 0.44%.

Gross Margin	13.29%
Operating Margin	2.51%
Pretax Margin	0.53%
Profit Margin	0.44%
EBITDA Margin	3.66%
EBIT Margin	2.51%
FCF Margin	1.95%

Dividends & Yields

This stock pays an annual dividend of 0.64, which amounts to a dividend yield of 3.43%.

Dividend Per Share	0.64
Dividend Yield	3.43%
Dividend Growth (YoY)	-3.01%
Years of Dividend Growth	2
Payout Ratio	192.14%
Buyback Yield	-0.71%
Shareholder Yield	2.71%
Earnings Yield	1.71%
FCF Yield	7.54%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CVS Health has an Altman Z-Score of 2.27 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.27
Piotroski F-Score	7